Research study Program year 2024 Source: CMS Open Payments

Phase IIa 8w

Research payments

$1,692,275

37 payments

Through program year 2024, $1,692,275 in research payments was reported against Phase IIa 8w, across 37 payments.

Paid by (largest first)
Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim RCV GmbH & Co KG; Boehringer Ingelheim International GmbH
ClinicalTrials.gov
No trial number was reported for this study

By program year

3 rows
Year Kind Amount Payments
2024 Research $507,155 12
2023 Research $1,122,224 11
2022 Research $62,897 14

Breakdown

Who paid Research payments · program years 2022–2024
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $1,646,430 19 payments
  2. Boehringer Ingelheim RCV GmbH & Co KG $44,795 15 payments
  3. Boehringer Ingelheim International GmbH $1,050 3 payments
Who received the money Research payments · program years 2022–2024
  1. Inland Empire Liver Foundation Organisation paid for research $917,869 8 payments
  2. American Research Corporation Organisation paid for research $380,977 5 payments
  3. California Liver Research Institute Organisation paid for research $318,179 9 payments
  4. Floridian Clinical Research Organisation paid for research $30,631 5 payments
  5. Feinstein Institute for Medical Research Organisation paid for research $20,570 1 payment
  6. American Research Corporation INC Organisation paid for research $10,039 3 payments
  7. Henry Ford Hospital Teaching hospital · MI $9,700 1 payment
  8. Floridian Health Centers LLC Organisation paid for research $2,075 1 payment
  9. Northwell Health Infectious Disease Organisation paid for research $1,184 1 payment
  10. Johns Hopkins Hospital Outpatient Organisation paid for research $350 1 payment

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record